In April, managed account provider Curian Capital released its annual survey of advisors' attitudes about the future. No surprise, most mentioned alternative investment and tactical allocation strategies as keys to client success in a still-turbulent global economy.
But in the wake of 2008, advisors are also sensitive to criticism about hyping hot, new investment ideas. They recognize the need for non-correlated asset classes in client portfolios, but also that the accompanying due diligence is now more crucial than ever.
Enter Private Client Resources, a Connecticut-based research and reporting firm, whose expertise is in "delivering faster, ever-more accurate data on complex wealth, and doing so with the highest level of client service."
No fly-by-night outfit is this. PCR counts Goldman Sachs' James Gorter, former Assistant Treasury Secretary Thomas Healey, as well as Herbert Aspbury, chairman of the board of trustees at Villanova University, as members of its advisory board (among others).
Robert Fiore, president and CEO of Private Client Resources, sat with Investment Advisor for a revealing interview about the alternative space.
What does the increase in the use of alternative investments say about the corresponding need for quality research in the space?
We see a primary need in transparency for the end client, and more and more advisors are looking to distinguish themselves with this transparency, especially post-2008. Pre-2008, client statements and reports were not very detailed or transparent. It looked like something you might receive from an accountant that was largely performance-driven.
Today, clients are looking for a greater level of oversight and governance: to be in partnership with their advisors. For that reason, advisors are looking to be better about explaining what's going on and the added value they bring to the relationship.
We know that the more sophisticated the client is, the more likely he is to have alternative investments, and [advisors will] need a mechanism for collecting, aggregating and reporting on the alternative investment portion of the portfolio, in conjunction with the rest, which is a science in and of itself.